New drug combo tested for safety in healthy volunteers
NCT ID NCT07312773
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test three experimental drugs (AD-231A, AD-231B, and AD-231C) in 55 healthy adults to see how they interact in the body and if they are safe. The drugs are being developed for high blood pressure and high cholesterol. Participants must be between 19 and 64 years old and have a healthy body weight.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H+ Yangji Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?